Doug Williams, new Sana R&D chief (Codiak website)
April 10, 2023 04:05 PM EDT
People
Bioregnum

In a bit­ter­sweet tran­si­tion, Doug Williams takes on his next big biotech chal­lenge

Doug Williams is mov­ing on.

Just days af­ter sound­ing taps in bank­rupt­cy court over Co­di­ak Bio­Sciences, where he helped spear­head the work as CEO …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times